ELI LILLY & Co — Director's Dealing 2022

Feb 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-02-01

Reporting Person: Skovronsky Daniel (SVP, CS&MO & Pres. LRL)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-01	Common Stock	M	18735	—	Acquired	64415	Direct
2022-02-01	Common Stock	F	8437	$245.39	Disposed	55978	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-01	Restricted Stock Unit	$	M	18735	Disposed	2022-02-01	Common Stock (18735.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70000	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.